share_log

Biofrontera Q1 2024 GAAP EPS $(2.88) Misses $(1.17) Estimate, Sales $7.912M Miss $10.857M Estimate

Benzinga ·  May 15 17:19

Biofrontera (NASDAQ:BFRI) reported quarterly losses of $(2.88) per share which missed the analyst consensus estimate of $(1.17) by 146.15 percent. This is a 48.57 percent increase over losses of $(5.60) per share from the same period last year. The company reported quarterly sales of $7.912 million which missed the analyst consensus estimate of $10.857 million by 27.12 percent. This is a 9.40 percent decrease over sales of $8.733 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment